4th Quarter - Report

ALIBABA GROUP HOLDING LIMITED for ALIBABA GROUP HOLDING LIMITED

Firm
Client
Income
—
Expenses
$610,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Small Business SMB

Small & medium sized enterprise trade promotion

LobbyistCovered position, as disclosed
BILL ANAYA —
EMILY ANN DAVIS —
JOHN MICHAEL EVANS —
XIAOHENG GENG —
SYDNEY STONE HAND —
MALCOLM LEE —
PAUL NAGLE —
ERIC PELLETIER —

Contacted: U.S. Trade Representative (USTR); Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Federal Trade Commission (FTC); Executive Office of the President (EOP); Consumer Product Safety Commission (CPSC); Treasury, Dept of; Patent & Trademark Office (PTO); State, Dept of (DOS)

Consumer Issues/Safety/Products CSP

Consumer product safety and e-commerce best practices

LobbyistCovered position, as disclosed
BILL ANAYA —
PAUL NAGLE —
ERIC PELLETIER —

Contacted: Commerce, Dept of (DOC); State, Dept of (DOS); Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Consumer Product Safety Commission (CPSC); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Patent & Trademark Office (PTO)

Travel/Tourism TOU

Growth and expansion of the Company's travel business and economic impact of increased travel to U.S.

LobbyistCovered position, as disclosed
BILL ANAYA —
SYDNEY STONE HAND —
PAUL NAGLE —
ERIC PELLETIER —

Contacted: Commerce, Dept of (DOC); Office of Management & Budget (OMB); Treasury, Dept of; Federal Trade Commission (FTC); Patent & Trademark Office (PTO); Executive Office of the President (EOP); U.S. Trade Representative (USTR); SENATE; State, Dept of (DOS); Food & Drug Administration (FDA); Consumer Product Safety Commission (CPSC); HOUSE OF REPRESENTATIVES

Science/Technology SCI

Technology policy issues. No specific legislation.

LobbyistCovered position, as disclosed
BILL ANAYA —
SYDNEY STONE HAND —
PAUL NAGLE —
ERIC PELLETIER —

Contacted: Office of Management & Budget (OMB); Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Treasury, Dept of; Federal Trade Commission (FTC); Consumer Product Safety Commission (CPSC); State, Dept of (DOS); SENATE; Patent & Trademark Office (PTO)

Economics/Economic Development ECN

Foreign direct investment and CFIUS reform and implementation generally

LobbyistCovered position, as disclosed
BILL ANAYA —
JOHN MICHAEL EVANS —
SYDNEY STONE HAND —
PAUL NAGLE —
ERIC PELLETIER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS); Treasury, Dept of; Executive Office of the President (EOP); Consumer Product Safety Commission (CPSC); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Patent & Trademark Office (PTO)

Health Issues HCR

E-commerce best practices to combat the sale of illegal drugs online

LobbyistCovered position, as disclosed
BILL ANAYA —
PAUL NAGLE —
ERIC PELLETIER —

Contacted: Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Executive Office of the President (EOP); Commerce, Dept of (DOC); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Consumer Product Safety Commission (CPSC); Treasury, Dept of

Trade (domestic/foreign) TRD

Small & medium sized enterprise and agriculture trade promotion; U.S. brand trade promotion

LobbyistCovered position, as disclosed
BILL ANAYA —
EMILY ANN DAVIS —
JOHN MICHAEL EVANS —
XIAOHENG GENG —
SYDNEY STONE HAND —
PAUL NAGLE —
ERIC PELLETIER —

Contacted: Commerce, Dept of (DOC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); SENATE; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); State, Dept of (DOS); Executive Office of the President (EOP); Consumer Product Safety Commission (CPSC); Treasury, Dept of

Copyright/Patent/Trademark CPT

Rights holder protection and anti-counterfeit initiatives

LobbyistCovered position, as disclosed
BILL ANAYA —
MATTHEW BASSIUR —
SYDNEY STONE HAND —
MALCOLM LEE —
PAUL NAGLE —
ERIC PELLETIER —

Contacted: SENATE; Commerce, Dept of (DOC); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Consumer Product Safety Commission (CPSC); Patent & Trademark Office (PTO); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Treasury, Dept of; Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.